Symptoms & treatment
Peptide News This Week: The FDA's Big BPC-157 Vote, a 22.6% Weight-Loss Result, and What It All Means for Your Midlife Health
An FDA panel voted to allow BPC-157 back in compounding pharmacies, and retatrutide hit 22.6% weight loss. Here is what this week's peptide news means for your midlife health.
July 26, 20267 min read
Hormone therapy
New ENDO 2026 Research: Hormone Therapy May Protect Your Bones, Brain, and Mood, Not Just Treat Hot Flashes
ENDO 2026 research links menopausal hormone therapy to a 69% lower risk of low bone density, plus cognitive and mood findings. What it means for your care.
July 10, 20265 min read